[Continuous theoretical training in onco-hematology for pharmacy technician's working in cytotoxic preparation unit].

Mise en place d’une formation continue théorique en onco-hématologie au sein d’une unité de préparation des anticancéreux.
Connaissances en onco-hématologie Continuous training Formation continue Knowledge assessment Onco-hematology Pharmacy technicians Préparateurs en pharmacie hospitalière Évaluation

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 31 10 2018
revised: 01 04 2019
accepted: 03 04 2019
pubmed: 30 5 2019
medline: 7 1 2020
entrez: 30 5 2019
Statut: ppublish

Résumé

Within the context of pharmacy technician's (PT) continuing training (CT), a theoretical instruction in onco-hematology has been developed for PT working in our cytotoxic preparation unit (CPU). The aim of this study is to describe the approach taken, tools used and present knowledge assessment (KA). A previous KA has been conducted using quiz available on GERPAC website which listing 36 drugs. Forty-five minutes sessions were conducted. KA was assessing before and after each session and 2 years after. PT appreciation was also evaluated. The previous KA served to targeting gaps and insisted on: indications, mechanism of action and cytotoxic drugs costs. Interactive sessions were led by a pharmacist and concerned about 17 diseases and 3 of the most prescribed cytotoxic drugs: 47 drugs summaries have been written by a pharmacist. The before-after knowledge improvement is significant (P>0.0005) (average [a] before=4.7 vs. a after=9.6). Two years after, this was non-significant but assessment results remain higher than before sessions (a=4.7 vs. 6.8). All PT wish sessions sustainability, 92% reported an adequate comprehension level. Lack of time and staff constitute a brake for sustaining and this was also highlighted by other units. Share this experience on a web platform could be interesting. Nevertheless, supports used during sessions should be suitable in conformity with the hospital practice and updated with new therapeutic.

Identifiants

pubmed: 31138436
pii: S0003-4509(18)30185-8
doi: 10.1016/j.pharma.2019.04.001
pii:
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

324-333

Informations de copyright

Copyright © 2019 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

M Moine (M)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: marionmoine0@gmail.com.

E Clou (E)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France.

M Bonsergent (M)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France.

D Sankhare (D)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France.

I Madelaine (I)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France.

N Jourdan (N)

Saint-Louis hospital, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH